# 2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women

> **NCT01173211** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 183 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Trivalent inactivated influenza vaccine
- **BIOLOGICAL:** Trivalent inactivated influenza vaccine
- **BIOLOGICAL:** Trivalent inactivated influenza vaccine

## Key facts

- **NCT ID:** NCT01173211
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 183 (ACTUAL)
- **Last updated:** 2014-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01173211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01173211, "2010-2011 Trivalent Influenza Vaccine (TIV) in Pregnant Women". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01173211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*